Global Antiviral Drug Resistance Market Estimated to Reach USD 4,000 Million by 2026

20-Mar-2020 | Facts and Factors

Findings from Facts and Factors report “Antiviral drug resistance Market By Product (Instruments and Kits & Reagents), By Disease Indication [Cytomegalovirus (CMV), Human Immunodeficiency Virus (HIV), and Hepatitis], By Technology [Next Generation Sequencing (NGS), Immunodiagnostics, Polymerase Chain Reaction (PCR), and Other Technologies], By End User (Research Institutes, Hospitals & Clinics, and Diagnostic or Pathology Laboratories), And By Region: Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026” states that the global antiviral drug resistance market surpassed USD 2,500 Million in 2019. The market is expected to grow at a CAGR of around 6.5% and is anticipated to reach close to USD 4,000 Million by 2026.

Antiviral drug resistance refers to a decline in the effectiveness of antiviral drugs that inhibit the proliferation of virion within the host cells and eventually eradicate the infectious particles from the host system. Any virus can acquire drug resistance characteristics through particular mutations in the genotype. In some instances, the drugs may completely lose their virus targeting efficiency, which is one of the mounting concerns among the patients with weak immune systems.

Browse the full “Antiviral drug resistance Market By Product (Instruments and Kits & Reagents), By Disease Indication [Cytomegalovirus (CMV), Human Immunodeficiency Virus (HIV), and Hepatitis], By Technology [Next Generation Sequencing (NGS), Immunodiagnostics, Polymerase Chain Reaction (PCR), and Other Technologies], By End User (Research Institutes, Hospitals & Clinics, and Diagnostic or Pathology Laboratories), And By Region: Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026" report at https://www.fnfresearch.com/global-antiviral-drug-resistance-market-by-product-instruments-833

The two key factors significantly driving the global antiviral drug resistance market are the constantly rising incidences of hepatitis infections and the increasing number of HIV/AIDS cases worldwide. However, the huge investment in developing novel & effective antiviral drugs along with the increasing prevalence of natural & organic products for treatment purposes are likely to impede the expansion of the global antiviral drug resistance market during the forecast period.

The “HIV infection” category under disease indication segment anticipates a splendid growth during the forecast period

The HIV infection segment will witness remarkable growth in the global antiviral drug resistance market segregated on the basis of disease indication. Moreover, the segment is likely to dominate the global industry in the coming years. The key factor considerably flourishing the HIV infection segment is the extensive hike in the number of HIV infection incidences.

North America is likely to hold the major revenue share generated by the global market during the forecast period

From the past few years, North America has been capturing the major share of the global drug market. Moreover, the regional is anticipated to attain the dominating position throughout the study timeframe owing to the establishment of the majority of the leading players in North America.

Report Scope

Some of the key players driving the global antiviral drug resistance market are Seimens AG, Bio-Rad Laboratories Inc., Abbott, Trinity Biotech, ACON Laboratories Inc., F. Hoffmann-La Roche Ltd., AccuBioTech Co. Ltd., Danaher, and BioMérieux SA, among others.

This report segments the global antiviral drug resistance market as follows:

Global Antiviral Drug Resistance Market: Product Segmentation Analysis

• Instruments
• Kits and Reagents

Global Antiviral Drug Resistance Market: Disease Indication Segmentation Analysis

• Cytomegalovirus (CMV)
• Human Immunodeficiency Virus (HIV)
• Hepatitis

Global Antiviral Drug Resistance Market: Technology Segmentation Analysis

• Next-Generation Sequencing (NGS)
• Immunodiagnostics
• Polymerase Chain Reaction (PCR)
• Other Technologies

Global Antiviral Drug Resistance Market:End-User Segmentation Analysis

• Research Institutes
• Hospitals & Clinics
• Diagnostic or Pathology Laboratories

Global Antiviral drug resistance Market: Regional Segmentation Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • Germany
  • The UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:

Facts & Factors

Global Headquarters

Level 8, International Finance Center, Tower 2,
8 Century Avenue, Shanghai,
Postal - 200120, China
Tel: +86 21 80360450

Email: [email protected]

Web: https://www.fnfresearch.com